» Articles » PMID: 32550151

The Optimal Vitamin D Cut-off Value Associated with Hyperglycemia in an Iranian Population

Overview
Specialty Endocrinology
Date 2020 Jun 19
PMID 32550151
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D deficiency may accelerate the risk of type 2 diabetes mellitus. The association of vitamin D with hyperglycemia may be influenced by lifestyle.

Objective: To evaluate the relationship between vitamin D status and hyperglycemia among the workers' population.

Methods: This was a medical records review of 7054 Iranian factory workers participating in an annual health check-up for employees. Of those, potential participants were included in this analysis if data for serum 25-hydroxyvitamin D [25(OH) D] levels were also available.

Results: Data of 429 male participants were used for this analysis. Of those, 61.07% had serum 25(OH)D concentrations lower than the sufficient level [≥20 ng/ml]. Hyperglycemic participants had significantly lower 25(OH)D than those with normal fasting blood glucose (FBG). Regression analyses highlighted serum 25(OH)D as a significant determinant of hyperglycemia [OR: 0.943(0.901, 988);  = 0.01]. The association between 25(OH)D and FBG remained significant after adjustment for potential confounders ( = 0.008). Using the ROC analysis, the serum 25(OH)D value of 14.7 ng/ml was the optimal cut-off point to predict hyperglycemia in this population (sensitivity: 63.6%, specificity: 62.3% = 0.01).

Conclusion: Our results revealed a considerable proportion of participants with serum 25(OH)D below the optimal level as well as a significant inverse association between vitamin D status and hyperglycemia among the factory workers. These findings highlight the importance of including the evaluation of vitamin D status as a part of annual health examinations for employees, and may help health policy- makers prevent or delay type 2 diabetes mellitus among the workers' population.

Citing Articles

Relationship Between Glycated Hemoglobin (HbA1c) and Vitamin D Levels in Type 2 Diabetes Patients: A Retrospective Cross-Sectional Study.

Abdo B, Abdullah M, Alshoaibi I, Ahmed F, Alawdi R, Alzanen K Cureus. 2024; 16(6):e62468.

PMID: 39015860 PMC: 11250245. DOI: 10.7759/cureus.62468.


Dietary pattern association with CD4 cells count in patients living with human immunodeficiency virus: A cross-sectional study.

Keshani P, Sarihi S, Parsaie N, Joulaei H J Public Health Res. 2023; 12(2):22799036231181200.

PMID: 37434871 PMC: 10331780. DOI: 10.1177/22799036231181200.


The Association of Serum Calcium and Vitamin D with Insulin Resistance and Beta-Cell Dysfunction among People with Type 2 Diabetes.

Hashim Z, Qasim Q, ALabbood M Arch Razi Inst. 2023; 77(5):1593-1600.

PMID: 37123134 PMC: 10133625. DOI: 10.22092/ARI.2022.357641.2081.


The relationship between estimated glucose disposal rate and bone turnover markers in type 2 diabetes mellitus.

Li Z, Qi C, Pan X, Jia Y, Zhao X, Deng C Endocrine. 2022; 77(2):242-251.

PMID: 35697964 DOI: 10.1007/s12020-022-03090-z.


Serum level of Vitamin D is associated with COVID-19 mortality rate in hospitalized patients.

Ranjbar M, Karbalaie Niya M, Roham M, Rezaie N, Yadollahzadeh M, Farrokhpour M J Res Med Sci. 2022; 26:112.

PMID: 35126575 PMC: 8765512. DOI: 10.4103/jrms.JRMS_1151_20.


References
1.
Al-Shoumer K, Al-Essa T . Is there a relationship between vitamin D with insulin resistance and diabetes mellitus?. World J Diabetes. 2015; 6(8):1057-64. PMC: 4515445. DOI: 10.4239/wjd.v6.i8.1057. View

2.
Azizieh F, Alyahya K, Raghupathy R . Association between levels of vitamin D and inflammatory markers in healthy women. J Inflamm Res. 2016; 9:51-7. PMC: 4854309. DOI: 10.2147/JIR.S103298. View

3.
Kienreich K, Tomaschitz A, Verheyen N, Pieber T, Gaksch M, Grubler M . Vitamin D and cardiovascular disease. Nutrients. 2013; 5(8):3005-21. PMC: 3775239. DOI: 10.3390/nu5083005. View

4.
Huang Y, Cai X, Mai W, Li M, Hu Y . Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016; 355:i5953. PMC: 5121106. DOI: 10.1136/bmj.i5953. View

5.
Pittas A, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan D . Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care. 2012; 35(3):565-73. PMC: 3322702. DOI: 10.2337/dc11-1795. View